Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) and Fresh Tracks Therapeutics (NASDAQ:FRTX – Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, analyst recommendations, earnings, valuation, dividends and institutional ownership. Institutional & Insider Ownership 64.3% of Acumen Pharmaceuticals […]
Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 50,400 shares, an increase of 366.7% from the May 15th total of 10,800 shares. Based on an average daily volume of 176,200 shares, […]
Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Rating) saw a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 50,400 shares, an increase of 366.7% from the May 15th total of 10,800 shares. Based on an average daily trading volume, of 176,200 shares, the short-interest […]
Qiagen (NYSE:QGEN – Get Rating) and Fresh Tracks Therapeutics (NASDAQ:FRTX – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, dividends, analyst recommendations and profitability. Analyst Recommendations This is a breakdown of current ratings for […]
Cortexyme (NASDAQ:CRTX – Get Rating) and Fresh Tracks Therapeutics (NASDAQ:FRTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations. Volatility & Risk Cortexyme has a beta of 1.4, […]